EMA explains EU incident management plan for human medicines

Earlier this week, the European Medicines Agency published the European Union regulatory network incident management plan for medicines for human use.

This plan, which has been in operation since September 2009, explains how the EMA, the European Commission and medicines regulatory authorities in the European Union member states work together to ensure that the most appropriate actions are taken across the EU whenever incidents (new events or information) arise concerning human medicines. It covers medicines authorized centrally, nationally and through the decentralized and mutual-recognition procedures.